The Master of Biomedical Innovation (MBI) program is a multidisciplinary, project-oriented graduate program focused on bridging the gap between technology development and its transfer into local, national, and international biomedical markets.
By linking the theory and practice of the biomedical innovation process, the program delivers a systematic but responsive approach to the critical, emerging discipline of innovation and entrepreneurship (I&E). Students of the program will:
Learn how to create and market biomedical products or devices.
Network and learn from renowned inventors and innovators.
Better understand emerging opportunities in therapeutics, artificial intelligence (AI), medtech, and more.
Admissions for 2026/2027 academic year are open.
International applications close December 31, 2025.
Domestic applications close March 14, 2026.
The MBI is a graduate-level program with the curriculum divided into three phases guiding learners through the
biomedical innovation and entrepreneurship process. Learners will simultaneously acquire and apply the theories and skillsets presented across the three phases to a venture-orientated project.
Information Box Group
Term 1 - Biomedical problem identification and exploration
Term 2 - Solutions design and prototyping
